WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 Issue has been successfully launched on OCTOBER 2024.

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE EFFECT OF HEIGHT AND WEIGHT ADJUSTED DOSE OF INTRATHECAL HYPERBARIC BUPIVACAINE FOR ELECTIVE CAESAREAN SECTION

Dr. Shawqi Abdul Sada Azeez*, Dr. Ali Saadoon Hashim, Dr. Ahmed Hussien Abd Janabi and Dr. Marwan Almashhadani

ABSTRACT

Background: The commonly observed hypotension during spinal block, if uncorrected, causes adverse effects on the mother and the neonate. The means to reliably prevent maternal hypotension under spinal anesthesia continues to elude the practicing anesthesiologist. Thus, one of the important methods to reduce hemodynamic changes would be to limit wide spread sympathetic block during spinal anesthesia. This can be achieved by restricting the spinal segment block desired for a caesarean section. While some studies have identified the patient's height and the sensory block level as risk factors for the hypotensive episodes in the mother during caesarean section others have been inconclusive. Nevertheless, the use of a dose of hyperbaric bupivacaine adjusted to patient's weight and height has shown to limit the spinal segment block spread. The dose adjustment study has been based on a Caucasian population and Nepalese women. No such study has been based on Iraqi women, where height is generally shorter than that of Caucasian women. Aim of the study: The study compared spinal anesthesia using intrathecal hyperbaric bupivacaine between height and weight adjusted dose and fixed dose during caesarean section. Methods: eighty parturient, who were scheduled for elective caesarean section under spinal anesthesia, were randomly assigned into two groups. We adjusted the intrathecal dose of heavy bupivacaine (0.5 %) according to the height and weight of patients (Group AD) from Harten’s dose chart developed from the Caucasian parturient and the fixed dose (2.5 ml) was used in Group FD patients. Keeping the observer blinded to the study groups, the sensory block up to T10, were observed. Results: we found that statistical differences in visual analogue scores, shivering, Ephedrine use, nausea and vomiting were significant in all readings. While, differences in Diastolic blood pressure were significant at 3min., 6 min., 9 min., 12 min., and 15 min. readings, and were insignificant at 25 min., 35 min., and 45 min. readings. No significant statistical differences in systolic blood pressure were found in all reading. Conclusions: the heavy bupivacaine dose adjusted on the basis of the chart of Harten significantly decreased the bupivacaine dose requirement compared with the usual dose use, with lesser incidence of hypotension, nausea and vomiting, and shivering during cesarean delivery

[Full Text Article] [Download Certificate]